We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective. 
Bharat Biotech - the manufacturer of Covaxin - has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data.
WHO is expecting one additional piece of information from the company today.
WHO is expecting one additional piece of information from the company today.
https://twitter.com/WHO/status/1450069244910129154
The timeframe for the WHO Emergency Use Listing procedure is dependent on how quickly a company producing the vaccine is able to provide the data required for WHO to evaluate the vaccine’s quality, safety, efficacy and its suitability for low- and middle-income countries.
https://twitter.com/WHO/status/1450069244910129154
When the information provided addresses all questions raised, WHO and the Technical Advisory Group will complete the assessment and come to a final recommendation whether to grant Emergency Use Listing to the vaccine.
https://twitter.com/WHO/status/1450069497642110978
• • •
Missing some Tweet in this thread? You can try to
force a refresh
